Oramed Pharmaceuticals, Inc.
(NASDAQ : ORMP)

( )
ORMP After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
JNJJohnson & Johnson 0.01%177.180.7%$1153.99m
LLYEli Lilly & Co. -0.05%371.791.1%$1049.81m
MRKMerck & Co., Inc. 0.70%110.860.7%$1003.98m
PFEPfizer Inc. 3.12%51.810.9%$984.69m
ABBVAbbVie, Inc. 0.28%165.871.9%$890.99m
BMYBristol-Myers Squibb Co. 0.00%79.931.1%$735.65m
AZNAstraZeneca Plc 0.47%69.171.0%$348.90m
HZNPHorizon Therapeutics Plc 0.63%96.915.4%$294.05m
GSKGSK Plc -0.77%36.600.3%$252.86m
IDXXIDEXX Laboratories, Inc. 2.01%428.543.9%$192.93m
NVSNovartis AG -0.15%91.590.2%$184.83m
ALNYAlnylam Pharmaceuticals, Inc. 2.89%238.018.0%$173.86m
CTLTCatalent, Inc. -3.53%45.561.9%$170.36m
NVONovo Nordisk A/S 2.08%127.840.1%$148.14m
SNYSanofi -2.13%46.920.2%$140.27m

Company Profile

Oramed Pharmaceuticals, Inc. engages in the provision of oral delivery solutions for drugs delivered via injection. It focuses on the research and development of pharmaceutical solutions, including an oral insulin capsule to be used for the treatment of individuals with diabetes, and the use of orally ingestible capsules or pills for delivery of other polypeptides. The company was founded by Nadav Kidron and Miriam Kidron on April 12, 2002 and is headquartered in New York, NY.